DexCom Receives Approval To Calibrate Its Glucose Monitoring System Using Any FDA-Cleared Blood Glucose Meter

San Diego, CA - DexCom, Inc. recently announced that it has received Food and Drug Administration (FDA) approval to calibrate the SEVEN, its seven-day continuous glucose monitoring system, using any FDA-cleared blood glucose meter. With this approval, patients will be able to calibrate the system without using a connection cable. DexCom expects to launch this feature to new patients near the end of the first quarter of 2008 and upgrade existing patients during the second quarter of 2008.

"We continue to believe that the introduction of new, more convenient products is key to the development of the continuous glucose monitoring category," said Terrance H. Gregg, DexCom's President and Chief Executive Officer. "We continue to be appreciative of efforts by the FDA to help make our technology advances available to people with diabetes and we are especially thankful for the support of the patients, physicians, nurses, and diabetes educators who have participated in our clinical studies and efforts supporting this approval."

SOURCE: DexCom, Inc.